Bone loss in adult offspring induced by low-dose exposure to teratogens

Arkady Torchinsky1, Limor Mizrahi, Shoshana Savion

  • 1Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, P.O. Box 39040, 69978, Tel Aviv, Israel. arkadyt@post.tau.ac.il

Insights

Prenatal exposure to a low-dose teratogen, 5-aza-2-deoxycytidine (5-AZA), can lead to bone loss in adult offspring. This occurs through altered microRNA expression and increased RANKL, impacting skeletal health.

Area of Science:

  • Developmental toxicology
  • Skeletal biology
  • Epigenetics

Background:

  • Maternal malnutrition and developmental toxicants can negatively impact offspring bone health.
  • Sub-threshold teratogen exposure may affect skeletal development without causing overt anomalies.

Purpose of the Study:

  • To investigate if sub-threshold teratogen exposure affects adult skeletal health.
  • To explore the underlying molecular mechanisms, including microRNA and RANKL expression.

Main Methods:

  • Pregnant mice received a single sub-threshold dose of 5-aza-2-deoxycytidine (5-AZA).
  • Skeletal microarchitecture of adult offspring was analyzed using micro-computed tomography.
  • Gene and protein expression (microRNAs, RANKL) were assessed in embryonic and adult tissues.

Main Results:

  • Offspring exposed to 5-AZA showed bone loss indicators in femora trabecular microarchitecture.
  • 5-AZA exposure increased susceptibility to stress-induced bone loss.
  • Altered microRNA expression in embryonic limb buds and increased RANKL in adult bone cells were observed.

Conclusions:

  • A single low-dose teratogen exposure can induce bone loss in adult offspring.
  • Mechanisms involve altered embryonic microRNA regulation and increased RANKL expression.
  • This highlights potential long-term skeletal risks from developmental toxicant exposure.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...